Predicting Future Price Moves In Cellebrite DI Ltd (CLBT)

Cellebrite DI Ltd (NASDAQ:CLBT) does about 986.02K shares in volume on a normal day but saw 582902 shares change hands in Friday trading. The company now has a market cap of 2.48B USD. Its current market price is $12.06, marking a decrease of -1.11% compared to the previous close of $12.20. The 52 week high reached by this stock is $12.67 whilst the lowest price level in 52 weeks is $6.36.

Cellebrite DI Ltd (CLBT) has a 20-day trading average at $11.86 and the current price is -4.78% off the 52-week high compared with 89.55% distance from its 52-week low. The 50-day simple moving average of the closing price is $11.38 and its 200-day simple moving average is $9.66. If we look at the stock’s price movements over the week, volatility stands at 2.26%, which increases to 3.16% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 58.24 to suggest the stock is neutral.

The consensus objective for the share price is $14.50, suggesting that the stock has a potential upside of 16.83% over the period.


The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 28, 2024 when Needham reiterated the stock to “Buy” and issued a price target of between $13 and $13.50. BofA Securities upgraded its price target at $9-$12.

Cellebrite DI Ltd (CLBT) stock is up 1.73% over the week and 15.90% over the past month. Its price is 39.32% year-to-date and 73.60% over the past year.


To reach the target analysts have set, the stock logically needs to grow 16.83 percent from here.

The company has a return on equity of -1768.51%. The forward price to earnings ratio is 50.97. The beta has a value of 1.50. Price to sales ratio is 7.21.